Skip to content

Wockhardt initiates phase-III clinical study of new antibiotic candidate

The company has completed the first site initiation visit for the study, Wockhardt said in a statement.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish